D

Dr Corp Ltd
SZSE:301177

Watchlist Manager
Dr Corp Ltd
SZSE:301177
Watchlist
Price: 23.55 CNY -5.27% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Dr Corp Ltd?
Write Note

Dr Corp Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dr Corp Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
D
Dr Corp Ltd
SZSE:301177
Other Receivables
ÂĄ36.9m
CAGR 3-Years
79%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Shenzhou International Group Holdings Ltd
HKEX:2313
Other Receivables
ÂĄ269.1m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
4%
ANTA Sports Products Ltd
HKEX:2020
Other Receivables
ÂĄ332m
CAGR 3-Years
-29%
CAGR 5-Years
-10%
CAGR 10-Years
10%
Li Ning Co Ltd
HKEX:2331
Other Receivables
ÂĄ232.1m
CAGR 3-Years
52%
CAGR 5-Years
43%
CAGR 10-Years
-6%
L
Lao Feng Xiang Co Ltd
SSE:600612
Other Receivables
ÂĄ500.4m
CAGR 3-Years
169%
CAGR 5-Years
66%
CAGR 10-Years
30%
Zhejiang Semir Garment Co Ltd
SZSE:002563
Other Receivables
ÂĄ687.2m
CAGR 3-Years
79%
CAGR 5-Years
10%
CAGR 10-Years
20%
No Stocks Found

Dr Corp Ltd
Glance View

Market Cap
9.4B CNY
Industry
Textiles, Apparel & Luxury Goods

In the bustling world of digital transformation, Dr Corp Ltd. has carved out its niche as an innovative leader that specializes in providing advanced software solutions tailored for the healthcare industry. Born out of a vision to streamline medical processes, the company has grown to become a pivotal player in the intersection of technology and medicine. At its core, Dr Corp Ltd. focuses on developing cutting-edge electronic health record systems, telemedicine platforms, and data analytics tools that aim to enhance patient care, streamline operations, and reduce costs for healthcare providers. Their suite of solutions is designed to integrate seamlessly into existing hospital infrastructure, offering medical practitioners intuitive tools for better data management and patient interaction. The revenue model of Dr Corp Ltd. is as sophisticated as its technology, embracing both subscription-based and licensing fees that provide a steady stream of income. Healthcare establishments often subscribe to Dr Corp's flagship software, drawn by its flexibility and ability to scale according to organizational needs. The company also capitalizes on its consulting services, offering bespoke solutions that include training and support to optimize the use of its products. This dual-pronged approach ensures a diversified income stream, allowing Dr Corp Ltd. to continually invest in research and development, staying ahead of technological curves and adapting to the ever-evolving demands of the healthcare industry. As a result, the firm maintains its reputation not only as a service provider but as a crucial partner in healthcare innovations.

Intrinsic Value
33.67 CNY
Undervaluation 30%
Intrinsic Value
Price
D

See Also

What is Dr Corp Ltd's Other Receivables?
Other Receivables
36.9m CNY

Based on the financial report for Dec 31, 2023, Dr Corp Ltd's Other Receivables amounts to 36.9m CNY.

What is Dr Corp Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
5%

Over the last year, the Other Receivables growth was 56%. The average annual Other Receivables growth rates for Dr Corp Ltd have been 79% over the past three years , 5% over the past five years .

Back to Top